Karam Al-Issa, MD

Key Publications

-Karam Al-Issa, Paul R. Helft. Narrative Review of Prognosis Related Communication In Advanced Cancer Patients. Annals of Palliative Medicine. Publication Status: Accepted

-Karam Al-Issa, Sravanti Rangaraju, and Ahmad Abdelfattah Al-Hader. Student loan debt and visa status influence on career choices for hematology and medical oncology fellows in the United States. Journal of Clinical Oncology 2020 38:15_suppl, 11024-11024 Publication Status: Published

-Nazha A, Al-Issa K, Hamilton BK, Radivoyevitch T, Gerds AT, Mukherjee S, Adema V, Zarzour A, Abuhadra N, Patel BJ, Hirsch CM, Advani A, Przychodzen B, Carraway  HE, Maciejewski JP, Sekeres MA. Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes. Leukemia. 2017 Dec;31 Publication Status: Published

-Nazha A, Al-Issa K, Przychodzen B, Abuhadra N, Hirsch C, Maciejewski JP, Sekeres MA. Differences in genomic patterns and clinical outcomes between African-American and White patients with myelodysplastic syndromes. Blood Cancer J. 2017 Sep 1;7(9):e602. Publication Status: Published

-Al-Issa K, Nazha A. Molecular landscape in acute myeloid leukemia: where do we stand in 2016?. Cancer Biol Med. 2016 Dec; Publication Status: Published

-Karam Al-Issa, Yazan Madanat, Sudipto Mukherjee, Cassandra M. Hirsch, Aaron T. Gerds, Nour Abuhadra, Ahed Makhoul, Hassan Awada, Mohammad F. Asad, Abhinav Goyal, Anjali Advani, Teodora Kosmanovic, Bartlomiej Przychodzen, Hetty E. Carraway, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Aziz Nazha. Model Heterogeneity in Predicting Survival of Patients with Myelodysplastic Syndromes (MDS): An Overestimation or Underestimation of Survival. ASH 2017; Atlanta

-Karam Al-Issa, Mikkael A. Sekeres, Alek d Nielsen, Babal Jha, Bartlomiej P Przychodzen, Mai Aly, Hetty E. Carraway, Anjali S. Advani, Bhumika Patel, Michael J. Clemente, Sudipto Mukherjee, Aaron T. Gerds, Jaroslaw P Maciejewski and Aziz Nazha. TP53 Mutations and Outcome in Patients with Myelodysplastic Syndromes (MDS). ASH 2016; San Diego.